Evan L. Wasoff

Chief Financial Officer, NEXIEN BIOPHARMA, INC.

Companies

NEXIEN BIOPHARMA, INC.Chief financial officer Oct 17, 2017 to May 28, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

NEXIEN BIOPHARMA, INC.6,500,000 shares²May 23, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

May 23, 2024Granted 2,000,000 shares of NEXIEN BIOPHARMA, INC.²
Oct 31, 2023Granted 250,000 shares of NEXIEN BIOPHARMA, INC.³
Jul 25, 2023Granted 250,000 shares of NEXIEN BIOPHARMA, INC.⁴
Apr 1, 2023Granted 250,000 shares of NEXIEN BIOPHARMA, INC.⁵
Jan 17, 2023Granted 250,000 shares of NEXIEN BIOPHARMA, INC.⁶
Oct 17, 2022Granted 250,000 shares of NEXIEN BIOPHARMA, INC.⁷
Jul 27, 2022Granted 250,000 shares of NEXIEN BIOPHARMA, INC.⁸
Apr 20, 2022Granted 250,000 shares of NEXIEN BIOPHARMA, INC.⁸
Jan 27, 2022Granted 250,000 shares of NEXIEN BIOPHARMA, INC.⁹
Nov 29, 2021Granted 500,000 shares of NEXIEN BIOPHARMA, INC.¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNEXIEN BIOPHARMA, INC., Chief financial officer
2
SEC EDGARNEXIEN BIOPHARMA, INC. shares after the filing of May 23, 2024
3
SEC EDGARForm 4 filed Nov 2, 2023
4
SEC EDGARForm 4 filed Jul 31, 2023
5
SEC EDGARForm 4 filed Apr 19, 2023
6
SEC EDGARForm 4 filed Jan 17, 2023
7
SEC EDGARForm 4 filed Oct 18, 2022
8
SEC EDGARForm 4 filed Sep 14, 2022
9
SEC EDGARForm 4 filed Jan 31, 2022
10
SEC EDGARForm 4 filed Nov 29, 2021